We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Concord Medical Services Holdings Ltd | NYSE:CCM | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.5158 | 0 | 09:09:37 |
RNS Number:2119U UBS Global Asset Management (UK)Ltd 14 January 2004 Date of Disclosure 14/01/2004 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing 13/01/2004 Dealing in CARLTON COMMUNICATIONS (name of company) 1) Class of securities (eg ordinary shares) ORD 5P 2) Amount bought Amount sold Price per unit 1,732 259.25P 3) Resultant total of the same class owned or controlled (and percentage of class) 58,049,906 (8.6%) 4) Party making disclosure UBS GLOBAL ASSET MANAGEMENT (UK) LTD 5) EITHER (a) Name of purchaser/vendor (Note 1) OR (b) if dealing for discretionary client(s), name of fund management organisation UBS GLOBAL ASSET MANAGEMENT (UK) LTD 6) Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) NO (ii) offeree company 2 & 6 YES Specify which category or categories of associate (1-8 overleaf) 2 & 6 If category (8), explain (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above N/A (Also print name of signatory) LOUISE TYLER Telephone and extension number 020 7901 5131 Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, eg where an owner normally acts on instructions of a controller Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or which an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8 Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed. Note 7. The resultant total percentage holding of the class of relevant security is to be calculated by reference to the percentage held and in issue outside treasury. For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No: 020 7638 0129. Email: monitoring@disclosure.org.uk This information is provided by RNS The company news service from the London Stock Exchange END DCCGCGDBSXBGGSS
1 Year Concord Medical Services Chart |
1 Month Concord Medical Services Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions